| Love: Arousiag “Alyce” Keshishian & Gregory Krikor Vartanian
Nov. 24 at St. Gregory the Illuminator Armenian Apostolic Church in Philadelphia. Father Nerses Manoogian officiated and a reception for 118 followed at the Drexelbrook in Drexel Hill. They met In August 2006. Alyce, 38, and Greg, 36, told everyone they met through their friend Kathy - kind of true, as it was Kathy who suggested that Alyce try an Armenian dating Web site. But the couple soon discovered they could have met in a more old-fashioned way, as their families have bumped into each other for decades: Alyce was born in Beirut, Lebanon, and a kind neighbor who was helping her young parents was the first to bathe the baby. Turns out this neighbor was Gregory's great-aunt Ankine. Alyce's cousins live next door to Greg's cousins in Toronto.
Thinking of spring training, Francoeur’s future
With so much attention understandably directed toward the return of Glavine, the situation with Teixeira, the huge question mark in center field, and other matters with the Braves, it's possible that much of their success could also ride on the continued development of their right fielder, who's now the veteran of the Braves outfield, a Gold Glove winner, the team's union player rep, and a team spokesman on many matters. That leadership is emerging, more and more. He's made for that role. Now, it'll be interesting to see how the future continues to unfold for former Atlanta-area prep phenom, the can't-miss prospect, the newlywed, the energetic, upbeat kid who so far been able to thrive despite nearly impossible expectations some have for him. Oh, and it'll obviously be interesting to see if and when he and the Braves come to a multi-year contract agreement that could both cement his status as a face of the franchise and possibly lift at least a little of the pressure off his sizeable shoulders.
AspenBio Pharma Reports Strong Results with Appendicitis Triage Blood ...
AppyScore(TM), the First Blood-based Screen / Triage Test for Human Appendicitis, Advances in FDA Application Process with Test Results Showing Sensitivity Level of 98%. CASTLE ROCK, Colo., Sept. 28 /PRNewswire-FirstCall/ -- AspenBio Pharma, Inc. (NASDAQ: APPY) an emerging bio-pharmaceutical company dedicated to the development of novel drugs and diagnostics for animals and humans, today announced strong results from the latest pre-FDA multi-hospital study using its AppyScore(TM) human appendicitis screen / triage blood test. AspenBio has also commenced the formal regulatory approval process for the AppyScore test by applying for a pre-investigational device exemption ("IDE") from the United States Food and Drug Administration ("FDA"). This large pre-FDA study was designed to provide a statistically significant confirmation of the performance, including utility and accuracy, of the AppyScore appendicitis screen / triage test in an emergency room setting.
|
